Učitavanje...
Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
Mazyar Shadman, MD, MPH, and Amy Goodrich, CRNP, reviewed data regarding the mechanistic activity, efficacy, and safety of approved and emerging therapeutic options for chronic lymphocytic leukemia (CLL) and strategies for managing adverse events associated with approved therapies for CLL.
Spremljeno u:
| Izdano u: | J Adv Pract Oncol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Harborside Press LLC
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857328/ https://ncbi.nlm.nih.gov/pubmed/33598332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.3.19 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|